Floatz logo

BMS 986253

Unresectable Solid Tumors

Yana Najjarmonoclonal_antibodyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Unresectable Solid Tumors cohort.

Asset / SponsorPhaseRating
Nivolumab
Yana Najjar
Phase 1CC

Same molecule, other indications

BMS 986253 is also rated in:

colon carcinomaDormant
CCC
Indicative ·
53 / 100
View asset →
COVID-19Dormant
CCC
Indicative ·
53 / 100
View asset →
hematopoietic and lymphoid system neoplasmDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →